Pharmacokinetic and pharmacodynamic interactions between simvastatin and diltiazem in patients with hypercholesterolemia and hypertension
- 3 December 2004
- journal article
- clinical trial
- Published by Elsevier in Life Sciences
- Vol. 76 (3) , 281-292
- https://doi.org/10.1016/j.lfs.2004.06.022
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Large Scale Cohort Study of the Relationship Between Serum Cholesterol Concentration and Coronary Events With Low-Dose Simvastatin Therapy in Japanese Patients With Hypercholesterolemia. Primary Prevention Cohort Study of the Japan Lipid Intervention Trial (J-LIT).Circulation Journal, 2002
- Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) studyThe Lancet, 2000
- The interaction of diltiazem with lovastatin and pravastatinPublished by Wiley ,1998
- Risk Factor Modification: Rationale for Management of DyslipidemiaThe American Journal of Medicine, 1998
- Plasma buspirone concentrations are greatly increased by erythromycin and itraconazole*Clinical Pharmacology & Therapeutics, 1997
- Non-invasive management of coronary artery diseaseThe Lancet, 1995
- Plasma Concentration Profiles of Simvastatin 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitory Activity in Kidney Transplant Recipients with and without CiclosporinNephron, 1993
- Regulation of the mevalonate pathwayNature, 1990
- Diltiazem and desacetyldiltiazem analysis in human plasma using high-performance liquid chromatography: improved sensitivity without derivatizationJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- DiltiazemDrugs, 1985